Piperazine sulfonamides as DPP-IV inhibitors: Synthesis, induced-fit docking and in vitro biological evaluation

Pubblicato online: 03 apr 2021

Pagine: 631 - 643

Accettato: 20 ott 2020

DOI: https://doi.org/10.2478/acph-2021-0034

Parole chiave

piperazine sulfonamide, dipeptidyl peptidase-IV inhibitor, diabetes mellitus, induced-fit docking

© 2021 Reema Abu Khalaf et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.